KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Zimmer Biomet Holdings (ZBH) has 6 years of Asset Writedowns and Impairment data on record, last reported at $289.8 million in Q4 2022.

  • For Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million; the TTM value through Dec 2022 reached $292.8 million, up 306.2%, while the annual FY2022 figure was $292.8 million, 1696.32% up from the prior year.
  • Asset Writedowns and Impairment reached $289.8 million in Q4 2022 per ZBH's latest filing, up from $3.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $975.9 million in Q4 2018 and bottomed at -$142.0 million in Q4 2020.
  • Average Asset Writedowns and Impairment over 4 years is $230.7 million, with a median of $51.6 million recorded in 2019.
  • The widest YoY moves for Asset Writedowns and Impairment: up 258.79% in 2018, down 88.38% in 2018.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $975.9 million in 2018, then crashed by 92.82% to $70.1 million in 2019, then tumbled by 302.57% to -$142.0 million in 2020, then soared by 304.08% to $289.8 million in 2022.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $289.8 million in Q4 2022, $3.0 million in Q2 2022, and -$142.0 million in Q4 2020.